Table 4.
Exploratory Unsuppressed Viral Load Subgroup Model Results, 1st/99th Percentile Truncated and Normalized
| Cohort | Tool of interest | Outcome of interest | Patients | Total patient-time | Estimate | Confidence interval |
|---|---|---|---|---|---|---|
| Refill access unsuppressed | Rx refill for ART | Viral load suppression | 400 | 1913 | 0.8114 | (0.5366, 1.227) |
| Refill access unsuppressed | Rx refill use | Viral load suppression | 400 | 1913 | 0.9164 | (0.6567, 1.2788) |
| Full access unsuppressed | Secure messaging | Viral load suppression | 501 | 2402 | 0.6603* | (0.4613, 0.9452) |
| Full access unsuppressed | View appointments | Viral load suppression | 501 | 2402 | 0.9913 | (0.7638, 1.2865) |
| Full access unsuppressed | View labs | Viral load suppression | 501 | 2402 | 1.5667* | (1.1184, 2.1949) |
Refill access = PLWH who at least have access to the Rx refill tool; full access = PLWH who have access to all tools. *Finding is significant at the α = 0.05 level